Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though ...
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
5d
Interesting Engineering on MSNFDA approves first-ever rapid-acting insulin biosimilar for diabetes treatmentThe FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...
“Our internal and external experts all believe that the implementational time frame, while not as fast as we had hoped, are ...
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...
WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric ...
Carrie Dennett answers your questions about carbohydrates and diabetes, lowering cholesterol with diet and lifestyle, and the ...
6d
MyNewsLA on MSNBloomberg Industry Group Sues Non-Profit Drug Manufacturer for Producing Insulin at Lower CostsThe Bloomberg Industry Group has filed a legal action against a state agency challenging the transparency of an agreement to allow a nonprofit drug manufacturer to produce insulin at lower costs in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results